Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin's lymphoma (HL) were evaluated
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic stem cell tra...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
WOS: 000392282500001PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognos...
PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognostic index after auto...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- MAR 22-25, 2015 ...
This study evaluates the outcome of 66 pediatric patients with rrHL who underwent autoHSCT. Twenty-n...
WOS: 000412118800010PubMed ID: 28571522We examined outcomes of 62 pediatric patients with relapsed o...
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of ca...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing...
AbstractHodgkin lymphoma (HL) prognostic models based on factors measured at time of autologous hema...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic stem cell tra...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...
WOS: 000392282500001PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognos...
PubMed ID: 27094103Objective: The prognostic factors and a new childhood prognostic index after auto...
Objective: The prognostic factors and a new childhood prognostic index after autologous hematopoieti...
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation -- MAR 22-25, 2015 ...
This study evaluates the outcome of 66 pediatric patients with rrHL who underwent autoHSCT. Twenty-n...
WOS: 000412118800010PubMed ID: 28571522We examined outcomes of 62 pediatric patients with relapsed o...
High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of ca...
Background: Novel agents are changing the treatment of relapsed or refractory Hodgkin lymphoma (HL)....
Background Post-transplant relapse has a dismal prognosis in children with acute leukemia undergoing...
AbstractHodgkin lymphoma (HL) prognostic models based on factors measured at time of autologous hema...
Most pediatric patients with Hodgkin lymphoma are cured of their disease with standard combined-moda...
Ninety-one children and adolescents 18 years or younger after allogeneic hematopoietic stem cell tra...
IF 11.855International audienceBackground:Novel agents are changing the treatment of relapsed or ref...